Ying Lin

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials

Hai T. Tran, Yuan Liu, Amado J. Zurita et al. · The Lancet Oncology · 2012 · 260 citations

Urology, Renal Function, Genitourinary Cancer +8

Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma

A. Benjamin Suttle, Howard Ball, Mathiéu Molimard et al. · British Journal of Cancer · 2014 · 180 citations · Full text

The Role of Aberrant VHL/HIF Pathway Elements in Predicting Clinical Outcome to Pazopanib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma

Toni K. Choueiri, André P. Fay, Robert Gagnon et al. · Clinical Cancer Research · 2013 · 85 citations

Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma

Yuanyuan Zhu, Zhangya Pu, Zhenfen Li et al. · Frontiers in Oncology · 2021 · 65 citations · Full text

Tumor Biology, Urology, Ccrcc Patients +15

A newly defined risk signature, consisting of three m6A RNA methylation regulators, predicts the prognosis of ovarian cancer

Lili Fan, Ying Lin, Lei Han et al. · Aging · 2020 · 45 citations · Full text